Diagnosis of heart failure in patients with chronic obstructive pulmonary disease
https://doi.org/10.36604/1998-5029-2024-91-123-133
Abstract
Introduction. Chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) frequently co-occur in clinical practice, presenting challenges in differential diagnosis due to shared risk factors, an adverse comorbid landscape, and nonspecific symptoms. The coexistence of COPD and CHF significantly affects the prognosis for both conditions because of their mutual exacerbation. Evaluating the heart's structural and functional status in COPD patients is essential for early identification of cardiovascular complications, thereby improving prognosis and reducing mortality.
Aim. To review the latest global literature on diagnosing heart failure in COPD patients. Materials and methods. This review compiles data from literature sources, primarily from the last five years, sourced from PubMed and eLibrary, incorporating older publications as necessary.
Results. The review discusses current laboratory diagnostics and medical imaging techniques for identifying heart failure, crucial for preventing severe complications. Primarily, transthoracic echocardiography stands out as the most accessible and cost-effective method, playing a pivotal role in diagnosing and monitoring heart failure today.
Conclusion. Heart failure is a subject of extensive publication with a detailed description of laboratory and instrumental methods, including the latest advances in magnetic resonance and computed tomography. Transthoracic echocardiography continues to be the "gold standard" in both the diagnostic and prognostic assessment of heart failure-related changes.
About the Authors
T. V. Sycheva
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
Tatyana V. Sycheva, Ultrasonographer, Postgraduate Student, Laboratory of Functional Research of Respiratory System,
22 Kalinina Str., Blagoveshchensk, 675000
J. M. Perelman
Far Eastern Scientific Center of Physiology and Pathology of Respiration
Russian Federation
Russian Federation
Juliy M. Perelman, MD, PhD, DSc (Med.), Professor, Corresponding Member of RAS, Deputy Director on Scientific Work,
22 Kalinina Str., Blagoveshchensk, 675000
References
1. Pellicori P., Cleland J.G.F., Clark A.L. Chronic obstructive pulmonary disease and heart failure: A breathless conspiracy. Cardiol. Clin. 2022; 40(2):171-182. https://doi.org/10.1016/j.ccl.2021.12.005
2. Karoli N.A., Borodkin A.V., Rebrov A.P. [Different origins of chronic heart failure in patients with chronic obstructive pulmonary disease]. Pulmonologiya 2016; 26(1):38-45 (in Russian). https://doi.org/10.18093/0869-0189-2016-26-1-38- 45
3. Mohammed R.A., Mohamed L.A., Abdelsalam E.M., Maghraby H.M., Elkenany N.M., Nabawi O.E., Sultan I. Assessment of cardiac dysfunction in patients with chronic obstructive pulmonary disease (COPD): A cross-sectional study. Cureus 2023; 15(5): e39629. https://doi.org/10.7759/cureus.39629
4. Sharma K., Kass D.A. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ. Res. 2014; 115(1);79-96. https://doi.org/10.1161/CIRCRESAHA.115.302922
5. Tasha T., Desai A., Bajgain A., Ali A., Dutta C., Pasha K., Paul S., Abbas M.S., Nassar S.T., Mohammed L. A literature review on the coexisting chronic obstructive pulmonary disease and heart failure. Cureus 2023; 15(10): e47895. https://doi.org/10.7759/cureus.47895
6. Daou D., Gillette T.G., Hill J.A. Inflammatory mechanisms in heart failure with preserved ejection fraction. Physiology (Bethesda) 2023; 38(5): 217-230. https://doi.org/10.1152/physiol.00004.2023
7. Farland M.Z., Peters C.J., Williams J.D., Bielak K.M., Heidel R.E., Ray S.M. β-blocker use and incidence of chronic obstructive pulmonary disease exacerbations. Ann. Pharmacother. 2013; 47(5): 651-656. https://doi.org/10.1345/aph.1R600
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2024 Report. Available at: https://goldcopd.org/2024-gold-report/
9. Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Belevskiy A.S., Leshchenko I.V., Ovcharenko S.I., Shmelev E.I. [Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease]. Pulmonologiya 2022; 32(3):356- 392 (in Russian). https://doi.org/10.18093/0869-0189-2022-32-3-356-392.
10. Khanji M.Y., Bicalho V.V., van Waardhuizen C.N., Ferket B.S., Petersen S.E., Hunink M.G. Cardiovascular risk assessment: A systematic review of guidelines. Ann. Intern. Med. 2016; 165(10):713-722. https://doi.org/10.7326/M16-1110
11. Morgan A.D., Zakeri R., Quint J.K. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther. Adv. Respir Dis. 2018; 12: 1753465817750524. https://doi.org/10.1177/1753465817750524
12. Zeng Q., Jiang S. Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure. J. Thorac. Dis. 2012; 4(3):310-315. https://doi.org/10.3978/j.issn.2072-1439.2012.01.09
13. Taylor C.J., Moore J., O'Flynn N. Diagnosis and management of chronic heart failure: NICE guideline update 2018. Br. J. Gen. Pract. 2019; 69(682):265-266. https://doi.org/10.3399/bjgp19X702665
14. Goyder C.R., Roalfe A.K., Jones N.R., Taylor K.S., Plumptre C.D., James O., Fanshawe T.R., Hobbs F.D.R., Taylor C.J. Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta-analysis. ESC Heart Fail. 2023; 10(3):1643-1655. https://doi.org/10.1002/ehf2.14314
15. Nasir S.A., Singh S., Fotedar M., Chaudhari S.K., Sethi K.K. Echocardiographic evaluation of right ventricular function and its role in the prognosis of chronic obstructive pulmonary disease. J. Cardiovasc. Echogr. 2020; 30(3):125- 130. https://doi.org/10.4103/jcecho.jcecho_10_20
16. Schäfer M., Humphries S., Stenmark K.R., Kheyfets V.O., Buckner J.K., Hunter K.S., Fenster B.E. 4D-flow cardiac magnetic resonance-derived vorticity is sensitive marker of left ventricular diastolic dysfunction in patients with mild-tomoderate chronic obstructive pulmonary disease. Eur. Heart J. Cardiovasc. Imaging 2018; 19(4):415-424. https://doi.org/10.1093/ehjci/jex069
17. Alekhin M.N., Bartosh-Zelenaya S.Yu., Beresten N.F., Boshchenko A.A., Vrublevskiy A.V., Glazun L.O., Kuznetsov V.A., Mitkov V.V., Mitkova M.D., Nartsissova G.P., Nelasov N.Yu., Novikov V.I., Pavlyukova E.N., Pestovskaya O.R., Rybakova M.K., Saidova M.A., Sandrikov V.A., Sedov V.P., Skidan V.I., Chernov M.Yu. [Standardization of transthoracic echocardiography in adults: an expert consensus statement from the Russian Association of Specialists in Ultrasound Diagnostics in Medicine (RASUDM) and the Russian Association of Specialists in Functional Diagnostics (RASFD)]. Ul- 'trazvukovaja i funkcional'naja diagnostika = Ultrasound and Functional Diagnostics 2021; (2):63-79 (in Russian). https://doi.org/10.24835/1607-0771-2021-2-63-79
18. Frost A., Badesch D., Gibbs J.S.R., Gopalan D., Khanna D., Manes A., Oudiz R., Satoh T., Torres F., Torbicki A. Diagnosis of pulmonary hypertension. Eur. Respir. J. 2019; 53(1): 1801904. https://doi.org/10.1183/13993003.01904-2018
19. Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., Carlsen J., Coats A.J.S., Escribano-Subias P., Ferrari P., Ferreira D.S., Ghofrani H.A., Giannakoulas G., Kiely D.G., Mayer E., Meszaros G., Nagavci B., Olsson K.M., Pepke-Zaba J., Quint J.K., Rådegran G., Simonneau G., Sitbon O., Tonia T., Toshner M., Vachiery J.L., Vonk Noordegraaf A., Delcroix M., Rosenkranz S.; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Heart J. 2022; 43(38):3618-3731. https://doi.org/10.1093/eurheartj/ehac237
20. Lechartier B., Kularatne M., Jaïs X., Humbert M., Montani D. Updated hemodynamic definition and classification of pulmonary hypertension. Semin. Respir. Cri.t Care Med. 2023; 44(6):721-727. https://doi.org/10.1055/s-0043-1770115
21. Avdeev S.N., Barbarash O.L., Bautin A.E., Volkov A.V., Veselova T.N., Galyavich A.S., Goncharova N.S., Gorbachevsky S.V., Danilov N.M., Eremenko A.A., Martynyuk T.V., Moiseeva O.M., Saidova M.A., Sergienko V.B., Simakova M.A., Stukalova O.V., Chazova I.E., Chernyavsky A.M., Shalaev S.V., Shmalts A.A., Tsareva N.A. [2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension]. Russian Journal of Cardiology 2021; 26(12):4683 (in Russian). https://doi.org/10.15829/1560-4071-2021-4683
22. Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K., Solomon S.D., Louie E.K., Schiller N.B. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23(7):685-713; quiz 786-788. https://doi.org/10.1016/j.echo.2010.05.010
23. D'Alto M., Di Maio M., Romeo E., Argiento P., Blasi E., Di Vilio A., Rea G., D'Andrea A., Golino P., Naeije R. Echocardiographic probability of pulmonary hypertension: a validation study. Eur. Respir. J. 2022; 60(2): 2102548. doi: 10.1183/13993003.02548-2021
24. Nikolaeva E.A., Martynyuk T.V. [New criteria for diagnosis of pulmonary arterial hypertension: pros and cons]. Systemic Hypertension 2023;20(2):21-27 (in Russian). https://doi.org/10.38109/2075-082X-2023-2-21-27
25. Kitabatake A., Inoue M., Asao M., Masuyama T., Tanouchi J., Morita T., Mishima M., Uematsu M., Shimazu T., Hori M., Abe H. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68(2):302-309. https://doi.org/10.1161/01.cir.68.2.302
26. Sumin A.N. Arkhipov O.G. [Markers of right ventricular diastolic dysfunction in patients with pulmonary hypertension]. Klinicheskaja medicina = Clinical Medicine 2018; 96(1):30-37 (in Russian). https://doi.org/10.18821/0023-2149-2018-96-30-37
27. Islamova M.R., Lazarev P.V., Safarova A.F., Kobalava Zh.D. [The value of right ventricular dysfunction and right ventricular - pulmonary artery coupling in chronic heart failure: The role of echocardiography]. Kardiologiia 2018; 58(5):82-90 (in Russian). https://doi.org/10.18087/cardio.2018.5.10124
28. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J. Cardiol. 1995; 26(2):135- 136.
29. [Chronic heart failure: clinical guidelines]. Moscow: Ministry of Healthcare RF, 2020 (in Russian). Available at: https://cr.minzdrav.gov.ru/schema/156_1
30. Cengiz Elçioğlu B., Kamat S., Yurdakul S., Şahin Ş.T., Sarper A., Yıldız P., Aytekin S. Assessment of subclinical left ventricular systolic dysfunction and structural changes in patients with chronic obstructive pulmonary disease. Intern. Med. J. 2022; 52(10):1791-1798. https://doi.org/10.1111/imj.15424
31. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A., Gendlin G.E., Glezer M.G., Gautier S.V., Dovzhenko T.V., Kobalava Zh.D., Koziolova N.A., Koroteev A.V., Mareev Yu.V., Ovchinnikov A.G., Perepech N.B., Tarlovskaya E.I., Chesnikova A.I., Shevchenko A.O., Arutyunov G.P., Belenkov Yu.N., Galyavich A.S., Gilyarevsky S.R., Drapkina O.M., Duplyakov D.V., Lopatin Yu.M., Sitnikova M.Yu., Skibitsky V.V., Shlyakhto E.V. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine. [Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment]. Kardiologiia 2018; 58(6S):8-158 (in Russian). https://doi.org/10.18087/cardio.2475
32. Nevzorova V.A., Zakharchuk N.V., Shapkina E.U., Kondrashova E.A., Kondrashov D.V. [COPD and preclinical cardiovascular disease]. South Russian Journal of Therapeutic Practice 2021; 2(2):70-79 (in Russian). https://doi.org/10.21886/2712-8156-2021-2-2-70-79
33. Rossi A., Aisanov Z., Avdeev S., Di Maria G., Donner C.F., Izquierdo J.L., Roche N., Similowski T., Watz H., Worth H., Miravitlles M. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir. Med. 2015; 109(7):785-802. https://doi.org/10.1016/j.rmed.2015.03.010
34. Chan N., Wang T.K.M., Anthony C., Hassan O.A., Chetrit M., Dillenbeck A., Smiseth O.A., Nagueh S.F., Klein A.L. Echocardiographic evaluation of diastolic function in special populations. Am. J. Cardiol. 2023; 202:131-143. https://doi.org/10.1016/j.amjcard.2023.05.032
35. Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F. 3rd, Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., Klein A.L., Lancellotti P., Marino P., Oh J.K., Popescu B.A., Waggoner A.D. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2016; 29(4):277-314. https://doi.org/10.1016/j.echo.2016.01.011
36. Burgess M.I., Mogulkoc N., Bright-Thomas R.J., Bishop P., Egan J.J., Ray S.G. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J. Am. Soc. Echocardiogr. 2002; 15(6):633-649. https://doi.org/10.1067/mje.2002.118526
37. Armentaro G., Pelaia C., Cassano V., Miceli S., Maio R., Perticone M., Pastori D., Pignatelli P., Andreozzi F., Violi F., Sesti G., Sciacqua A. Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients. Eur. J. Clin. Invest. 2023; 53(2): e13887. https://doi.org/10.1111/eci.13887
38. Cherneva Z., Valev D., Youroukova V., Cherneva R. Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease – a step forward in cardiovascular comorbidome. PLoS One 2021; 16(3): e0247940. https://doi.org/10.1371/journal.pone.0247940
39. Faria R.A., Goulart C.L., Santos P.B., Marinho R.S., Firmino S.M., Rizzatti F.P.G., Mendes R.G., Borghi-Silva A., Roscani M.G. Association of right ventricle diastolic diameter with pulmonary function, exercise tolerance and exacerbation period in patients with chronic obstructive pulmonary disease: A prospective study. Heart Lung 2022; 55:11-15. https://doi.org/10.1016/j.hrtlng.2022.04.003
Review
For citations:
Sycheva T.V., Perelman J.M. Diagnosis of heart failure in patients with chronic obstructive pulmonary disease. Bulletin Physiology and Pathology of Respiration. 2024;(91):123-133. (In Russ.) https://doi.org/10.36604/1998-5029-2024-91-123-133
Views:
164
Email this article 